Company intelligence / Profile preview

Stepan Company

Northbrook/Northfield area, Illinois, USAstepan.com ↗
Ownership
Public · SCL
Employees
~2200
Development stage
Commercial
01

Overview

Stepan Company manufactures specialty and intermediate chemicals, including surfactants, polyols, esters, and excipients used in pharmaceuticals, personal care products, nutritionals, agriculture, and industrial applications. It does not develop or market finished pharmaceutical products or therapies but supplies key raw materials to the healthcare sector[2][3][5].

The company operates globally with a diversified customer base across multiple industries. It has a long track record of financial stability and dividend growth[6]. Its pharmaceutical-related offerings include high-purity esters/fats/oils for medical nutrition/dietary supplements and select APIs/excipients such as sodium lauryl sulfoacetate and benzalkonium chloride[3].

While it plays an important role in the supply chain for pharma/nutrition companies by providing essential chemical building blocks and excipients—sometimes under strict regulatory standards—it does not itself conduct drug discovery or clinical development.

The company also uniquely processes coca leaves at its New Jersey facility to produce cocaine-free extracts for Coca-Cola; the extracted cocaine alkaloid goes to Mallinckrodt for medicinal use under DEA authorization[2].

Recent news includes divestment of certain manufacturing assets in the Philippines as part of strategic focus on core growth areas[4].

R&D investments focus on new chemical solutions rather than drug development. Manufacturing capabilities are extensive with global reach.

Key leadership includes CEO Luis Rojo.

Publicly traded on NYSE under symbol SCL.

Headquarters in Northbrook/Northfield area near Chicago; operations span Americas, Europe & Asia-Pacific regions.

Modalities
Small molecule
Industry
Chemicals & Materials
02

Partnerships

DKSH (distribution partner)[8]
03

Financials

Market cap
$1.4B
Total revenue
$684.1M
Enterprise value
$2B

Beyond the preview

Go deeper on Stepan Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stepan Company.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call